Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: A nationwide cohort study

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 1, 2016, Pages 90-99

  Heinze, Georg ^a   Jandeck, Lisanne M ^a   Hronsky, Milan ^a   Reichardt, Berthold ^b   Baumgärtel, Christoph ^c   Bucsics, Anna ^d,e   Müllner, Marcus ^c,f   Winkelmayer, Wolfgang C ^g,h  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Burgenland Regional Health Insurance Fund   (Austria)

^c AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^d Main Association of Austrian Social Security Institutions   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

^f PERI Consulting GmbH   (Austria)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anatomical therapeutic chemical (ATC) classification system; Diabetes mellitus; Drug utilization; Duplicate prescription; Hyperlipidemia; Hypertension; Pharmacoepidemiology

Indexed keywords

AMLODIPINE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; BISOPROLOL; FLUINDOSTATIN; GLICLAZIDE; INSULIN ASPART; INSULIN LISPRO; LISINOPRIL; METFORMIN; REPAGLINIDE; SIMVASTATIN; SITAGLIPTIN;

AGED; ARTICLE; AUSTRIA; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE FINANCING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNIST; MALE; PATIENT CARE; PATIENT SAFETY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; DRUG COST; ECONOMICS; HYPERLIPIDEMIAS; INAPPROPRIATE PRESCRIBING; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA;

ANTIHYPERTENSIVE AGENTS; AUSTRIA; COHORT STUDIES; DIABETES MELLITUS; DRUG COSTS; DRUG PRESCRIPTIONS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INAPPROPRIATE PRESCRIBING; PATIENT SAFETY; PREVALENCE;

EID: 84953837033     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3898     Document Type: Article

References (22)

1. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27(5): 1218-1224.
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353(5): 487-497.
3. Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care 2010; 48(3): 196-202.
4. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008; 155(4): 772-779.
5. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166(17): 1836-1841.
6. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007; 167(6): 540-550.
7. Cutler DM, Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med 2010; 362(17): 1553-1555.
8. Cutrona SL, Choudhry NK, Fischer MA, et al. Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care 2010; 16(12): 929-942.
9. Bennett CL, Schwarz B, Marberger M. Health care in Austria. Universal access, national health insurance, and private health care. JAMA: J Am Med Assoc 1993; 269(21): 2789-2794.
10. Bundesministerium für Gesundheit. The Austrian Health Care System. Key Facts, Updated version 2013. Vienna, 2013. Available at: http://www.bmgf.gv.at/cms/home/attachments/3/4/4/CH1066/CMS1291414949078/austrian_health_care_key_facts_2013.pdf (accessed 27 June 2015)
11. Leopold C, Habl C. Pharmaceutical Pricing and Reimbursement Information: Austria, Pharma Profile, pp. IV-VI. Vienna, 2008. ISBN 978-3-85159-120-0, available at: http://apps.who.int/medicinedocs/documents/s17125e/s17125e.pdf (accessed 27 June 2015)
12. Le Polain M, Franken M, Koopmanschap M, Cleemput I. Drug Reimbursement Systems: international Comparison and Policy Recommendations, pp. 69ff. Belgian Health Care Knowledge Centre, Brussels, 2010. Available at: https://kce.fgov.be/sites/default/files/page_documents/KCE_147C_Drug_reimbursement_systems_4.pdf (accessed 27 June 2015)
13. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo, 2012. ISBN 978-82-8082-525-4. available at: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf (accessed 27 June 2015)
14. White H. Maximum likelihood estimation of misspecified models. Econometrica 1982; 50(1): 1-25.
15. Harrell F Jr. rms - Regression Modeling Strategies. R package, Version 3.6-3. available at: http://cran.r-project.org/web/packages/rms (accessed 27 June 2015)
16. Benichou J. Attributable Risk. In Encyclopedia of Epidemiologic Methods, Gail MH, Benichou J (eds.). Wiley: Chichester, 2000.
17. International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 2008; 17(2): 200-208.
18. Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Nat Cancer Inst 2007; 99: 592-600.
19. Hofmarcher M. Pharmaceutical Safety Belt: e-health kicks in. Health Policy Monitor 2008;12. available at: http://www.hpm.org/de/Surveys/IHS_-_Oesterreich/12/Pharmaceutical_Safety_Belt__e-health_kicks_in.html (27 June 2015 2015)
20. Ammenwerth E, Duftschmid G, Gall W, Hackl WO, Hoerbst A, Janzek-Hawlat S, Jeske M, Jung M, Woertz K, Dorda W. A nationwide computerized patient medication history: evaluation of the Austrian pilot project "e-Medikation". Int J Med Inform 2014; 83: 655-669. doi:10.1016/j.ijmedinf.2014.06.004.
21. Hsu MH, Yeh YT, Chen CY, Liu CH, Liu CT. Online detection of potential duplicate medications and changes of physician behavior for outpatients visiting multiple hospitals using national health insurance smart cards in Taiwan. Int J Med Inform 2011; 80: 181-189.
22. Kaushal R, Kern LM, Barron Y, Quaresimo J, Abramson EL. Electronic prescribing improves medication safety in community-based office practices. J Gen Intern Med 2010; 25(6): 530-536.